Molecular tumor boards show promise in bridging precision oncology's translation gap
By
Margaret M. Byrne,
6d ago· 6 min readenInsight
Summary
This Perspective article examines the "translation gap" in precision oncology—the challenge of turning complex genomic data into actionable treatment decisions. The authors discuss how Molecular Tumor Boards (MTBs), which bring together multidisciplinary experts to interpret genomic findings, can bridge this gap. They reference a new meta-analysis showing MTBs improve clinical outcomes, and explore how to expand MTB use feasibly and equitably across healthcare settings.
Source
bskyMolecular tumor boards show promise in bridging precision oncology's translation gapplos.ioKey quotes
· 3 pulledMolecular tumor boards translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost clinical outcomes.
In this Perspective, Margaret Byrne and Jill Kolesar discuss how we may feasibly and equitably expand the use of MTBs.
Precision oncology's translation gap—Can molecular tumor boards bridge it?
Molecular tumor boards translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost clinical outcomes. In this Perspective, Margaret Byrne and Jill Kolesar discuss how we may feasibly and equitably
You might also wanna read
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·12d ago
Harmonizing standards and resources for the medical genome
Nature Communications·7d ago
Distributed Biomanufacturing: Rethinking Production and Logistics for Autologous Cell Therapies
bioprocessintl.com·22d ago
Cell- and Virus-Bank Characterization in Product Development: A Risk-Based, Phase-Appropriate Framework for Quality Control
bioprocessintl.com·1d ago
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
mdsc.pe·18d agoDual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.